Pro,Elegant,-,Eye,$18,laagvlieger.x24hr.com,WearMe,Electronics , Computers Accessories , Computer Accessories Periphera,Oval,/Agathaumas42889.html,Premium,Fra,Glasses,Cat,Light,Blue $18 WearMe Pro - Premium Elegant Blue Light Glasses Cat Eye Oval Fra Electronics Computers Accessories Computer Accessories Periphera WearMe Pro Super beauty product restock quality top! - Premium Elegant Blue Eye Fra Oval Light Glasses Cat $18 WearMe Pro - Premium Elegant Blue Light Glasses Cat Eye Oval Fra Electronics Computers Accessories Computer Accessories Periphera WearMe Pro Super beauty product restock quality top! - Premium Elegant Blue Eye Fra Oval Light Glasses Cat Pro,Elegant,-,Eye,$18,laagvlieger.x24hr.com,WearMe,Electronics , Computers Accessories , Computer Accessories Periphera,Oval,/Agathaumas42889.html,Premium,Fra,Glasses,Cat,Light,Blue

WearMe Pro Super beauty product restock quality Max 46% OFF top - Premium Elegant Blue Eye Fra Oval Light Glasses Cat

WearMe Pro - Premium Elegant Blue Light Glasses Cat Eye Oval Fra

$18

WearMe Pro - Premium Elegant Blue Light Glasses Cat Eye Oval Fra

|||

Product description

WearMe Pro was founded in 2011 with one simple goal – to provide high end fashion without the high end price tag. You shouldn’t have to take out a personal loan in order to look and feel good. Thankfully, with WearMe Pro, the latest trends are more affordable than ever. At WearMe Pro, our focus is on producing the highest possible quality sunglasses at the lowest possible price. Our designs take inspiration from the very latest trends, bringing you styles that often haven’t even made it into the stores of the high-end retailers. All of our lenses are 100% UVA and UVB protected, and every pair comes with a microfiber cloth/case, to ensure your sunglasses stay clean and scratch free for years to come. Why should you choose WearMe Pro? We are a family owned company with a customer-centric philosophy – we’re only happy if you’re happy! We hand pack our orders, and love to hear our clients’ thoughts on both our products and fashion in general. We understand that our customers are the lifeblood of our business, so if you’ve got any thoughts or recommendations on trends or designs, don’t hesitate to contact us! On top of the incredible quality and value of our products, we also offer a 30 day satisfaction guarantee, allowing you to return or exchange your sunglasses absolutely free, and we offer free domestic shipping within the USA. The latest looks and the highest quality construction at a fraction of the price. That’s the WearMe Pro difference.


Product Description

WearMe Pro Blue light glassesWearMe Pro Blue light glasses

WearMe Pro - Premium Elegant Blue Light Glasses Cat Eye Oval Fra

Health Tech

B2C Greater London

Get Inflow secures £486k Pre-Seed investment led by Rhythm VC

First science-based digital program for ADHD community raises

B2C HealthTech

10Amp Circuit Breakers Manual Reset 32VDC,AC125-250V with Quick

STRESS-FREE FUNDING ROUND FOR WELLBEING TECH FIRM Thrive

B2C Greater London

Spill App secures £2 million Seed investment led by Ada Ventures

Mental health startup Spill raises £2 million to

B2C Greater London

Pangaea Data secures Seed Follow On investment led by IQ Capital

Pangaea Data raises further funding to accelerate deployment

B2B B2C

eConsult Health secures £7 million Series A investment led by Gresham House Ventures

eConsult Health attracts £7m new investment eConsult Health

Female Led Grant

Vinehealth Digital secures £1 million grant from Innovate UK

‘Vinehealth secures £1m Innovate UK Grant to improve

Subscribe to Weekly Deal News

Delivered every Monday to your inbox

£5.32/month

London-based GlamorousAI secures £440k grant funding from Innovate UK

London-based GlamorousAI Secures Grant From Innovate UK to Fund a $500k Project toward Development of New Treatments For Glioblastoma Multiforme.  GlamorousAI, a leading artificial intelligence biotech company pioneering innovation in small data drug discovery, and King’s College London enter into a collaboration to unlock new drug development opportunities for Glioblastoma Multiforme. The company announced today funding from Innovate UK to apply its AI-first platform, Rosalind, to the discovery of novel therapeutic targets, biomarkers and leads for Glioblastoma Multiforme.  Glioblastoma Multiforme is the most common and aggressive brain tumour in adults affecting more than 100,000 people annually. Despite multimodal therapy, the

read more

Oxbotica secures £34.45 million Series B investment led by bp

OXBOTICA RAISES $47 MILLION TO DEPLOY AUTONOMY SOFTWARE PLATFORM AROUND THE WORLD Oxbotica raises $47 million cementing its position as a global leader in autonomous vehicle softwareInvestment raised from across the globe including Australia, China, UK, and the USA with bp ventures a lead investorOxbotica demonstrates the commercial viability of its universal autonomy software platform, deploying in industries today London, UK, Wednesday 6th January 2021: Oxbotica, a global leader in autonomous vehicle software, has announced the completion of a $47 million Series B investment with partners across the globe led by bp ventures. The funding will accelerate Oxbotica’s commercial deployment of

read more

SearchSmartly secures £1.25 million Seed investment from angel investors, Founders

SearchSmartly redefines the home search experience with £1.25million investment Rising demand for housing is leading to a flooded market for buyers and sellers, SearchSmartly allows home buyers to cut through the noise in a matter of minutes with its smart match-making property search platformSearch Smartly provides hyper-personal property searches in London and the Home Counties, and will expand across the UK urban centresLeading investors in the property and tech are supporting this £1.25million seed investment SearchSmartly is also the first property platform to highlight the air quality rating on its properties, reflecting growing consumer concern around air quality in urban areas.

read more

Exscientia secures £21.54 million Series C Follow On investment from

Exscientia completes $100 million Series C financing round with BlackRock funds Proceeds to further accelerate AI drug discovery platform and pipeline OXFORD, 4th March 2021 – Exscientia, a clinical stage pharmatech pioneering the use of artificial intelligence (AI) to design new drugs, today announced that funds managed by BlackRock joined the Company’s Series C investment round. Including existing Series C investors, Novo Holdings, Evotec, Bristol Myers Squibb, and GT Healthcare Capital, the round totalled $100 million in funding. This new capital will be used to support Exscientia’s platform development towards  autonomous drug design. In addition, the company will extend its proprietary pipeline

read more

Peptone secures £1.84 million Seed investment led by Hoxton Ventures

Peptone’s protein engineering operating system which speeds up medicine development secures $2.5m investment 8 January 2021, London, UK: In a year that has seen scientists heralded as heroes and the future of protein-based medicine has sat at the coalface of a pandemic, one startup is looking to increase the pharmaceutical industry’s chances of developing future medicines quicker than ever before. Peptone, the computational physics company, has built the world’s first protein engineering operating system and, thanks to $2.5 million seed round led by Hoxton Ventures and supported by dRx Capital, a venture arm of Novartis Pharma AG, Founders Factory and

read more

nPlan secures £13.43 million Series A investment led by GV

London, UK, 23 March 2021: nPlan, a company that uses machine learning to forecast the duration, risks and opportunities of construction projects, has secured an $18.5 million investment round, led by GV (formerly Google Ventures). The company’s proprietary AI algorithms have analysed nearly $1 trillion worth of global construction projects and deploys this learning to spot delays and recommend improvements with an accuracy and scale previously not possible. In doing so, nPlan’s data-led insights effectively reduce the volatility of and increase investor confidence in construction projects. There continues to be a significant global appetite for major infrastructure projects, both in the

read more

Limitless Technology secures £7.3 million Series B investment led by

Limitless Announces $10m Series B, adds Genesys as Investor and Technology Partner UK GigCX platform innovator Limitless continues global expansion and accelerates CX transformation with Genesys Cloud integration and new investment led by Redline Capital February 2, 2021: London, UK - Limitless, the AI-driven gig customer experience platform, today announced it has raised $10 million in financing. The Series B investment is led by Redline Capital and features new investment from Genesys, as well as continued participation from AlbionVC and Unilever Ventures. In addition to its latest funding achievements, Limitless also recently entered into a new technology partnership with Genesys, which was announced today by the global leader in cloud customer and contact

read more

XYZ Reality secures £20 million Series A investment led by

XYZ REALITY SECURES £20M SERIES A FUNDING AS IT PREPARES FOR COMMERCIAL LAUNCH Transformational Augmented Reality (AR) platform sets a new standard in construction. Uses holograms to deliver megaprojects across Europe. Innovative use of holograms on construction sites enables construction teams to view and build accurately from 3D design models.XYZ Reality's technology has been used on projects totalling a value of over £1.5bn to date, across complex construction projects including data centres, pharmaceutical facilities and airports.Trailblazing construction technology eliminates errors made in the building process – a £10bn to £25bn per year problem in the UK alone.Major Series A investment from Octopus Ventures

read more

Synthesia secures £9 million Series A investment led by FirstMark

Synthesia announces $12.5M Series A to replace cameras with code and scale their AI video generation platform. Synthesia, the rapidly growing AI video generation platform, secures $12.5 million in Series A funding, making it the largest investment in AI video space to date.The funding round is led by FirstMark Capital, the NY-based early stage fund, and also adds two new angels to the cap table: Christian Bach (CEO, Netlify) and Michael Buckley (VP Communications, Twilio). All existing investors are also participating in the round: LDV Capital, MMC Ventures, Seedcamp, MarK Cuban, Taavet Hinrikus, Martin Varsavsky and TinyVC.The funding will be

read more

Aflorithmic Labs secures £1 million Seed investment from Crowd Media

Voice Cloning AI Startup Aflorithmic Raises £1M, Making Affordable, Personalized Text-to-Voice Audio A Reality For Marketers and Content Creators  London, February 3, 2020, Aflorithmic Labs Ltd, a London/Barcelona based AI Audio-As-A-Service startup, announced today that it has raised a £1 Million Seed Round from Australian media company Crowd Media Holdings (ASX: CM8 & FWB: CM3).  Aflorithmic enables fully automated, scalable audio production by using synthetic media, voice cloning and audio mastering, to then deliver it onto any device or platform. With this Audio-As-A-Service, anybody can create beautiful, podcast-quality audio, tailored to each individual listener. Get Deal News in your inbox

read more